Preponderant impact of the chemosensitivity assessed by the modeled CA-125 kinetic parameter KELIM on the success of the first line treatment: Pooled analysis of AGO-OVAR 7, AGO-OV... von You, B., Tod, M., Leary, A., Ray-Coquard, I., Lortholary, A., Hardy-Bessard, A.C., Perren, T., Cook, A., Pfisterer, J., Bois, A.D., Kurzeder, C., Burges, A., Peron, J., Freyer, G., Colomban, O.

Volltext

Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network von Derquin, F., Floquet, A., Hardy-Bessard, A.C., Edeline, J., Lotz, J.P., Alexandre, J., Pautier, P., Angeles, M.A., Delanoy, N., Lefeuvre-Plesse, C., Cancel, M., Treilleux, I., Augereau, P., Lavoue, V., Kalbacher, E., Berton Rigaud, D., Selle, F., Nadeau, C., Gantzer, J., Joly, F., Guillemet, C., Pomel, C., Favier, L., Abdeddaim, C., Venat-Bouvet, L., Provansal, M., Fabbro, M., Kaminsky, M.C., Lortholary, A., Lecuru, F., Coquard, I. Ray, de La Motte Rouge, T.

Volltext

Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study von Bourgeois, H., Grudé, F., Solal-Céligny, P., Dupuis, O., Voog, E., Ganem, G., Denis, F., Zinger, M., Juhel-Voog, L., Lafond, C., Maillart, P., Capitain, O., Delva, R., Soulié, P., Abadie-Lacourtoisie, S., Guérin-Meyer, V., Morin-Meschin, M.E., Commer, J.M., Gangler, A., d’Aillières, B., Zannetti, A., Bourbouloux, E., Berton-Rigault, D., Lebouvier-Sadot, S., Kaassis, M., Baudon, J., Lam, Y.H., Bizieux, A., Marcq, M., Edeline, J., Le Du, F., Lefeuvre, C., Deguiral, P., Delecroix, V., Blot, E., Egreteau, J., Goudier, M.J., Lamy, R., Ferec, M., Artignan, X., Corbinais, S., Morel, H., Hardy-Bessard, A.C., Alleaume, C., Naudeix, E., Cojocarasu, O., Metges, J.P., Riché, C., Gamelin, E., Déniel-Lagadec, D., Marhuenda, F., Ingrand, P., Douillard, J.Y.

Volltext

The predictive value of the CA-125 modeled kinetic parameter KELIM is validated in 3 independent datasets (AGO-OVAR 7 & 9; ICON 7 AGO/GINECO/GCIG trials) von You, B.M., Colomban, O., Tod, M., Ray-Coquard, I.L., Lortholary, A., Hardy-Bessard, A.C., Du Bois, A., Huober, J., Meier, W., Kurzeder, C., Pfisterer, J.

Volltext

Perfuração traumática de hérnia perineal secundaria a amputação abdominoperineal por câncer de reto inferior von Junior, H. Samartine, Junior, A.J.T. Alves, Hardy, A.C., Banci, S.O., Delatti, F.A., Gomes, F.P., Neto, J. Simoes, Neto, J.A. Reis

Volltext

A propos de la signification médicale d'une prescription. Commentaire von HARDY, A.C

Volltext

Efficacy of cabazitaxel, abiraterone, enzalutamide and docetaxel sequence in men with metastatic castration-resistant prostate cancer (mCRPC) in real life practice: The multination... von Angelergues, A., Birtle, A.J., Hardy-Bessard, A.C., Caffo, O., Moulec, S.L.e., Krainer, M., Guillot, A., Hasbini, A., Daugaard, G., Chowdhury, S., Spaeth, D., Beuzeboc, P., Eymard, J.-C., Flechon, A., Alexandre, J., Priou, F., Delanoy, N., El Awadly, N., Braychenko, E., Oudard, S.

Volltext

Paclitaxel‐carboplatin‐gemcitabine (TCG) as first‐line treatment of ovarian cancer: a prospective multicenter phase II study (AGO‐OVAR 8) followed by a prospectively randomized pha... von BOIS, A., SEHOULI, J., LUND, B., JOLY, F., HUOBER, J., JENSEN, T.S., LEVY, E., HEILMANN, V., BOMAN, K., HARDY‐BESSARD, A.C., BURGES, A., MÄENPÄÄ, J., PUJADE‐LAURAINE, E., PFISTERER, J., GROPP, M., STAEHLE, A., WIMBERGER, P., JACKISCH, C., SCHMALFELDT, B., BELAU, A., LOIBL, S., WOLLSCHLAEGER, K., CANZLER, U., ROCHON, J.

Volltext

5193 Can adjuvant homeopathy improve the control of post-chemotherapy emesis in breast cancer patients? Results of a randomized placebo-controlled trial von Ray-Coquard, I, Provençal, J, Hardy-Bessard, A.C, Bachelot, T, Coeffic, D, Jacquin, J.P, Guastalla, J.P, Agostini, C, Bajard, A, Pérol, D

Volltext

HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group von Camilleri-Broët, S., Hardy-Bessard, A. C., Le Tourneau, A., Paraiso, D., Levrel, O., Leduc, B., Bain, S., Orfeuvre, H., Audouin, J., Pujade-Lauraine, E.

Volltext

Results of time-resolved radiation exposure measurements made during U.S. Shuttle missions with a tissue equivalent proportional counter von Golightly, M.J., Hardy, A.C., Hardy, K.

Volltext

Organ radiation doses and lifetime risk of excess cancer for several space shuttle missions von Atwell, W, Hardy, A.C, Peterson, L.E

Volltext

Description, analysis and impact of major solar activity during recent U.S. shuttle missions von Golightly, M.J., Hardy, A.C., Atwell, W., Hardy, K.

Volltext

An American Machine in Europe von Hardy, A.C

Volltext

Servicing the Aircraft Engineer von Hardy, A.C

Volltext

P32 Prognostic parameters in node negative breast cancer receiving adjuvant CMF: Analysis of a randomized trial with emphasis on p53 and HER 2 neu von Hardy-Bessard, A.C., De Roquancourt, A., Cottu, P.H., De Cremoux, P., Marty, M., Espie, M.

Volltext

A parametric study of space radiation exposures to critical body organs for low earth orbit missions von Atwell, W., Beever, E.R., Hardy, A.C.

Volltext

Reply to “Window insulation against traffic noise” von Hardy, A.C., Lewis, P.T.

Volltext

The graininess of photographic materials used in the motion picture industry von Hardy, A.C., Jones, Loyd A.

Volltext

An American Machine in Europe: The Ford Trimotor Compared with Current Practice in English and Continental Passenger Machines von Hardy, A.C.

Volltext